Services on Demand
Journal
Article
Indicators
- Cited by SciELO
Related links
- Similars in SciELO
Share
Revista Peruana de Medicina Experimental y Salud Publica
Print version ISSN 1726-4634On-line version ISSN 1726-4642
Abstract
SOTO-CABEZAS, M. Gabriela et al. Comorbidities associated with COVID-19 mortality in adults in Lima, Peru: a retrospective cohort study. Rev. perú. med. exp. salud publica [online]. 2023, vol.40, n.2, pp.132-140. Epub June 30, 2023. ISSN 1726-4634. http://dx.doi.org/10.17843/rpmesp.2023.402.12170.
Objectives.
To evaluate comorbidities associated with mortality in adult patients hospitalized due to COVID-19 in hospitals in Lima and Callao.
Materials and methods.
In this retrospective cohort study, we analyzed data from adult patients hospitalized due to COVID-19 reported to the National Epidemiological Surveillance System of the Peruvian Ministry of Health from March to October 2020. We estimated relative risks with 95% confidence intervals using Poisson regression models with robust variance to assess comorbidities associated with mortality by age group: young adults (18-29 years), adults (30-59 years) and older adults (≥60 years).
Results.
We included 2366 young adults, 23,781 adults and 25,356 older adults. Older adults had the highest mortality (63.7%) compared to adults (27.1%) and young adults (8.5%). Regardless of age group, the presence of neurological disease, renal disease, liver disease, and cancer was associated with an increased risk of mortality. Additionally, cardiovascular disease was also a risk factor in young adults; obesity, diabetes, cardiovascular disease, chronic lung disease, and immunodeficiency in adults; and obesity and chronic lung disease in the elderly.
Conclusions.
Regardless of age groups, individuals with chronic neurologic disease, renal disease, liver disease, and cancer were at high risk of death from COVID-19.
Keywords : COVID-19; Comorbidity; Prognosis; Hospitalization; Peru.